Published by Abigail Townsend on 23rd March 2021
(Sharecast News) - A cocktail of antibodies developed by Roche and Regeneron Pharmaceuticals to treat Covid-19 has been shown to cut hospitalisation or death by 70%, the Swiss drugmaker said on Tuesday.
URL: http://www.digitallook.com/dl/news/story/31727150/...